Patent · US Active

Wired implantable monolithic integrated sensor circuit

US11806136B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Inventors

Muhammad Mujeeb-U-Rahman · Irvine, US
Meisam Honarvar Nazari · Pasadena, US
Mehmet Sencan · Pasadena, US

Key dates

Filing date	Jan 5, 2023
Grant date	Nov 7, 2023
Priority date	—
Expiry date	Jan 5, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61B2562/12
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

There is provided a glucose sensor system comprising: a transmitter (2) for containing a battery (212), the transmitter being for placement on top of patient skin; a transcutaneous connector (3) comprising at least one conductive path; and an implantable monolithic integrated circuit (I) for placement beneath the patient skin, wherein the implantable monolithic integrated circuit comprises a potentiostat and an electrochemical sensing element; wherein the potentiostat is electrically coupled to the transmitter (2) via the transcutaneous connector (3), and the electrochemical sensing element is configured to sense glucose concentration and generate an electrical signal representative of the glucose concentration, and wherein the potentiostat is electrically connected to the electrochemical sensing element.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.